Wolverine Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-940
| Closed | -$9.88K | – | 1144 |
|
|
2024
Q4 | $9.88K | Sell |
940
-972
| -51% | -$10.2K | ﹤0.01% | 946 |
|
|
2024
Q3 | $25.1K | Hold |
1,912
| – | – | ﹤0.01% | 831 |
|
|
2024
Q2 | $26.9K | Buy |
+1,912
| New | +$26.9K | ﹤0.01% | 837 |
|
|
2024
Q1 | – | Sell |
-5,912
| Closed | -$83.5K | – | 1267 |
|
|
2023
Q4 | $83.5K | Hold |
5,912
| – | – | ﹤0.01% | 766 |
|
|
2023
Q3 | $60.9K | Hold |
5,912
| – | – | ﹤0.01% | 844 |
|
|
2023
Q2 | $97.4K | Buy |
+5,912
| New | +$97.4K | ﹤0.01% | 752 |
|
|
2021
Q4 | – | Sell |
-7,791
| Closed | -$76K | – | 1713 |
|
|
2021
Q3 | $76K | Hold |
7,791
| – | – | ﹤0.01% | 1067 |
|
|
2021
Q2 | $52K | Hold |
7,791
| – | – | ﹤0.01% | 1424 |
|
|
2021
Q1 | $70K | Hold |
7,791
| – | – | ﹤0.01% | 1306 |
|
|
2020
Q4 | $52K | Sell |
7,791
-2,700
| -26% | -$18K | ﹤0.01% | 1033 |
|
|
2020
Q3 | $52K | Buy |
+10,491
| New | +$52K | ﹤0.01% | 976 |
|
|
2014
Q3 | – | Sell |
-6,002
| Closed | -$90K | – | 1146 |
|
|
2014
Q2 | $90K | Buy |
+6,002
| New | +$90K | ﹤0.01% | 800 |
|